reports
Carriage Services Announces First Quarter 2024 Results
Carriage Services Announces First Quarter 2024 Results Conference call on Thursday, May 2, 2024 at 9:30 a.m. central time HOUSTON, May 01, 2024 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced its financial results for the first quarter ended March 31, 2024. Company Highlights: Total revenue of $103.5 million led to growth of 8.4% over the prior-year quarter, primarily driven by a 38.4% increase in cemetery preneed sales;GAAP diluted EPS of $0.45 and Adjusted diluted EPS of $0.75, compared to $0.57 and $0.56 in the prior-year quarter, respectively;Completed the ...
Cytokinetics to Host Investor Event and Conference Call to Discuss the...
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European Summer Time (11:00 AM Eastern Time) to discuss the primary results from SEQUOIA-HCM (Safety, Efficacy, and Quantitative Understanding of Obstruction Impact of Aficamten in HCM), which are being presented in a...
Cytokinetics Inc: 1 director
A director at Cytokinetics Inc sold 10,562 shares at 64.540USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Cytokinetics to Announce First Quarter Results on May 8, 2024
Cytokinetics to Announce First Quarter Results on May 8, 2024 SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report first quarter results on May 8, 2024 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company’s outlook for the future. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinet...
AdvanSix Awarded Third Consecutive Platinum Rating for Corporate Socia...
PARSIPPANY, N.J.--(BUSINESS WIRE)-- AdvanSix (NYSE: ASIX) has been recognized with its third consecutive Platinum rating by EcoVadis, an independent corporate social responsibility assessment agency. The Platinum rating is EcoVadis’ highest rating and puts the company in the top one percent of all companies assessed. “Earning three consecutive, world-leading Platinum ratings from EcoVadis is a compelling recognition of the hard work and achievements of our AdvanSix teammates, who embed responsible and sustainable business practices into delivering for our customers, communities and our stake...
Capital City Bank Group, Inc. Reports First Quarter 2024 Results
Capital City Bank Group, Inc. Reports First Quarter 2024 Results TALLAHASSEE, Fla., April 22, 2024 (GLOBE NEWSWIRE) -- Capital City Bank Group, Inc. (NASDAQ: CCBG) today reported net income attributable to common shareowners of $12.6 million, or $0.74 per diluted share, for the first quarter of 2024 compared to $11.7 million, or $0.70 per diluted share, for the fourth quarter of 2023, and $13.7 million, or $0.80 per diluted share, for the first quarter of 2023. QUARTER HIGHLIGHTS (1st Quarter 2024 versus 4th Quarter 2023) Income Statement Tax-equivalent net interest income totale...
Carriage Services Declares Quarterly Cash Dividend
Carriage Services Declares Quarterly Cash Dividend HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced that its Board of Directors on April 18, 2024 declared a quarterly dividend of 11.25¢ per share payable on June 3, 2024 to common share record holders as of May 6, 2024. Carriage Services is a leading provider of funeral and cemetery services and merchandise in the United States. Carriage Services operates 165 funeral homes in 26 states and 31 cemeteries in 11 states. For more information, please email .
Carriage Services Announces 2024 First Quarter Earnings Release and Co...
Carriage Services Announces 2024 First Quarter Earnings Release and Conference Call Schedule HOUSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Carriage Services, Inc. (NYSE: CSV) today announced plans to release 2024 first quarter results on Wednesday, May 1, 2024 after the market closes. In conjunction with the release, Carriage Services has scheduled a conference call, which will be broadcast live over the Internet on Thursday, May 2, 2024 at 9:30 a.m. central time. What:Carriage Services First Quarter 2024 Earnings Conference CallWhen:Thursday, May 2, 2024 – 9:30 a.m. central time How:Live v...
Rocket Pharmaceuticals Inc: 1 director
A director at Rocket Pharmaceuticals Inc sold 12,532 shares at 24.638USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Fluent Announces Reverse Stock Split
Fluent Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on April 12, 2024 NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, today announced that it will effect a 1-for-6 reverse split of the issued shares of its common stock, effective at 6:00 p.m. Eastern Time on April 11, 2024. The Company's common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Friday, April 12, 2024. Following the reverse stock split, the Company’s common stoc...
Cytokinetics Announces Three Late Breaking Clinical Trial Presentation...
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress Primary Results from SEQUOIA-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Two Additional Analyses from SEQUOIA-HCM Assess Effect of Aficamten on Exercise Capacity and Dosing and Safety SOUTH SAN FRANCISCO, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three Late Breaking Clinical Trial presentations relating to SEQU...
AdvanSix to Release First Quarter Financial Results and Hold Investor ...
PARSIPPANY, N.J.--(BUSINESS WIRE)-- AdvanSix (NYSE: ASIX) will issue its first quarter 2024 financial results before the opening of the New York Stock Exchange on Friday, May 3. The company will also hold a conference call with investors at 9:00 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. ET start and tell the operator that you are dialing in for AdvanSix’s first quarter 2024 earnings call. A replay of the conference call will be available from...
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Ope...
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session Treatment with Aficamten for 48 Weeks is Associated with Improvements in Clinical Efficacy Endpoints, NYHA Class and Cardiac Biomarkers, Structure and Function SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in ...
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Ope...
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session Treatment with Aficamten for 48 Weeks is Associated with Improvements in Clinical Efficacy Endpoints, NYHA Class and Cardiac Biomarkers, Structure and Function SOUTH SAN FRANCISCO, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in ...
Influencer Media Group Infuse Follows Up on Stellar 2023 Growth with N...
Influencer Media Group Infuse Follows Up on Stellar 2023 Growth with New Partnership, Podcast Launch, and Influencer Events NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Following an extraordinary year of growth for Fluent’s influencer network Infuse, the brand is proudly announcing a strategic partnership with influencer agency THIS Group Inc. This partnership underscores Infuse's commitment to fostering influencer talent and maximizing their potential in the dynamic landscape of influencer marketing. As a Fluent brand, Infuse opens up numerous integrated marketing opportunities for infl...
Fluent Announces Fourth Quarter and Full-Year 2023 Financial Results
Fluent Announces Fourth Quarter and Full-Year 2023 Financial Results Revenue of $72.8 million for Q4 2023 and $298.4 million for FY 2023Net loss of $1.9 million for Q4 2023 and $63.2 million for FY 2023Gross profit (exclusive of depreciation and amortization) of $20.8 million for Q4 2023 and $78.5 million for FY 2023Media margin of $24.1 million for Q4 2023 and $91.3 million for FY 2023Adjusted EBITDA of $2.5 million for Q4 2023 and $6.8 million for FY 2023Adjusted net loss of $0.4 million for Q4 2023 and $7.2 million for FY 2023 NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc...
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 563...
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 29, 2024 it granted stock options to purchase an aggregate of 78,000 shares of common stock to five new employees, whose employment commenced in March 2024, as a material inducement to their employment. The stock options that were granted are subject to an exercise price of $70.11 per share, which is equal to the closing price of the Company’s common stock on March 28, 2024, an...
AdvanSix Achieves ISCC PLUS Certification Advancing Sustainable Manufa...
PARSIPPANY, N.J.--(BUSINESS WIRE)-- AdvanSix (NYSE: ASIX), a diversified chemistry company, today announced it has been certified to the International Sustainability and Carbon Certification (ISCC) PLUS standard for three of its manufacturing sites, including Frankford, Pa., Hopewell, Va. and Chesterfield, Va. is a globally recognized, voluntary certification system for developing sustainable supply chains. Verified through an in-depth audit, the ISCC PLUS certification verifies and validates the adoption of clear, transparent and traceable practices, especially for organizations applying t...
Fluent, Inc. to Announce Fourth Quarter and Full-Year 2023 Financial R...
Fluent, Inc. to Announce Fourth Quarter and Full-Year 2023 Financial Results on April 2, 2024 NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial results for the fourth quarter and fiscal year ended December 31, 2023, after the close of the U.S. financial markets on April 2, 2024. Fluent will host a conference call at 4:30 pm ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at or via audio at . The call will also be webcast simultaneously on the Fluent w...
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthc...
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024 at 2:15 PM Eastern Time. Interested parties may access the live webcast of this fireside chat by visiting the Investors & Media section of the Cytokinetics website at . The webcast replay will be ar...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.